STAGE IV LUNG CANCER AJCC V8

This study tested whether a mobile app that guides patients through a time-restricted eating schedule could help protect their memory and thinking skills and improve survival after radiation treatment for brain metastases. The trial was designed for adults with breast or lung can…

This early-stage study tested whether combining two immunotherapy drugs (atezolizumab and varlilumab) with targeted radiation could help control advanced non-small cell lung cancer that had stopped responding to standard treatments. The main goal was to check if this three-part c…

This early-phase study tested the safety and effectiveness of adding a new drug called plinabulin to a combination of radiation and immunotherapy. It was for patients with advanced cancers (like lung, bladder, and melanoma) that had continued to grow despite prior immunotherapy. …

This early-phase trial tested the safety and initial effectiveness of a new immunotherapy drug (BMS-986218), given alone or with another immunotherapy drug (nivolumab), alongside targeted radiation therapy. It was for adults with advanced solid cancers that had spread to other pa…

This study tested whether adding an immunotherapy drug called bintrafusp alfa to standard chemotherapy (docetaxel) could better control advanced non-small cell lung cancer in patients whose cancer had worsened despite previous treatment with immunotherapy and chemo. The trial aim…

This early-phase study tested a combination of two drugs, bintrafusp alfa and pimasertib, for patients with cancer that had spread to the brain (brain metastases). The goal was to find a safe dose and see if the combination could help control the brain tumors and help patients li…